Older patients with inflammatory bowel disease who initiate Entyvio therapy had lower risk for hospitalization than those treated with anti-TNF, according to research presented at the Crohn’s and Colitis Congress.
Bharati Kochar, MD, from Massachusetts General Hospital, said that while older adults make up a large portion of patients with IBD in the United States, they are not well represented in clinical trials.